Semble, a London, UK-based provider of an integrated clinical system and innovator in healthtech, raised $15M in Series B funding.
The round was led by Mercia Ventures with participation from Octopus Ventures, Smedvig Ventures and Triple Point.
The company intends to use the funds to support the ongoing growth of the platform as it looks to expand in the UK and France.
Founded by Christoph Lippuner and Mikael Landau, Semble is a provider of an integrated clinical system that allows healthcare businesses of all sizes to manage their practice. The platform is designed to streamline workflows and deliver insight for better patient and business outcomes. It is used by over 10,000 healthcare professionals across the UK and France, supporting more than 70 specialties.
FinSMEs
29/10/2024